CD34 + selected cells in clinical transplantation
- 1 January 1994
- journal article
- review article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 12 (6), 577-585
- https://doi.org/10.1002/stem.5530120605
Abstract
The CD34 antigen is expressed by early hematopoietic stem cells and progenitors and is detected on the surface of approximately 1% of bone marrow mononuclear cells [1‐3]. Several monoclonal antibody‐based methods have been developed to isolate these cells from clinical samples of bone marrow or peripheral blood based on their expression of this antigen, utilizing either biotin‐avidin affinity, panning or immunomagnetic beads. Roughly 50% of CD34+ cells, with 20‐90% purity, are recovered from clinical samples using these methods. Several clinical trials have demonstrated hematopoietic recovery using CD34+ selected cells to support high dose therapy. CD34+ cells may be useful in several areas of clinical stem cell transplantation, including purging of tumor cells, T cell depletion, stem cell expansion and gene therapy. This paper reviews the current methods for purification of CD34+ cells from clinical samples and discusses potential uses of these cells in transplantation.Keywords
This publication has 27 references indexed in Scilit:
- CD34 selection for purging in multiple myeloma and analysis of CD34+b cell precursorsThe International Journal of Cell Cloning, 1994
- Efficient isolation of human CD34 positive hemopoietic progenitor cells by immune panningThe International Journal of Cell Cloning, 1994
- Gene-marking to trace origin of relapse after autologous bone-marrow transplantationThe Lancet, 1993
- Selection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1Science, 1992
- Human gene therapy comes of ageNature, 1992
- RAPID ISOLATION OF HUMAN CD34 HEMATOPOIETIC STEM CELLS—PURGING OF HUMAN TUMOR CELLSTransplantation, 1992
- Isolation of a candidate human hematopoietic stem-cell population.Proceedings of the National Academy of Sciences, 1992
- Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell LymphomaNew England Journal of Medicine, 1991
- Human hematopoietic precursors in long-term culture: single CD34+ cells that lack detectable T cell, B cell, and myeloid cell antigens produce multiple colony-forming cells when cultured with marrow stromal cells.The Journal of Experimental Medicine, 1990
- Antigen CD34+ marrow cells engraft lethally irradiated baboons.JCI Insight, 1988